tiprankstipranks
UMP Healthcare Holdings Limited (HK:0722)
:0722
Hong Kong Market
Want to see HK:0722 full AI Analyst Report?

UMP Healthcare Holdings Limited (0722) AI Stock Analysis

3 Followers

Top Page

HK:0722

UMP Healthcare Holdings Limited

(0722)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
HK$0.50
▲(3.96% Upside)
Action:Downgraded
Date:06/14/26
The score is driven primarily by solid financial stability (low leverage and strong free cash flow) and supportive valuation (moderate P/E and high dividend yield). Offsetting these positives are weaker recent profitability trends and soft technical momentum signals.
Positive Factors
Free Cash Flow Strength
Consistent and rising free cash flow provides durable internal funding for clinic upkeep, expansion, and dividends. Strong cash conversion in 2025 improves flexibility to invest in patient services or return capital without relying on external financing, supporting resilience over months.
Negative Factors
Net Margin Compression
A sharp drop in net margin signals structural pressure on profitability—higher operating costs, pricing pressure, or mix shift. Sustained lower margins reduce retained earnings, constrain reinvestment capacity and dividend sustainability unless operational fixes restore margin over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Free Cash Flow Strength
Consistent and rising free cash flow provides durable internal funding for clinic upkeep, expansion, and dividends. Strong cash conversion in 2025 improves flexibility to invest in patient services or return capital without relying on external financing, supporting resilience over months.
Read all positive factors

UMP Healthcare Holdings Limited (0722) vs. iShares MSCI Hong Kong ETF (EWH)

UMP Healthcare Holdings Limited Business Overview & Revenue Model

Company Description
UMP Healthcare Holdings Limited, an investment firm, delivers a broad spectrum of medical and wellness provisions across Hong Kong, Macau, and mainland China. The company's operations are divided into two main divisions: Corporate Healthcare Solut...
How the Company Makes Money
null...

UMP Healthcare Holdings Limited Financial Statement Overview

Summary
Balance sheet and cash flow are solid (low, stable leverage and consistently positive/free cash flow), supporting financial resilience. However, operating performance has weakened: revenue dipped in 2025 and profitability/returns compressed materially versus prior years.
Income Statement
56
Neutral
Balance Sheet
74
Positive
Cash Flow
72
Positive
BreakdownTTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue723.59M727.36M748.49M727.75M666.20M617.16M
Gross Profit490.27M490.61M692.25M502.69M463.95M456.28M
EBITDA79.81M80.24M161.98M178.21M170.15M170.44M
Net Income31.88M31.44M40.64M60.45M72.17M34.83M
Balance Sheet
Total Assets1.12B1.10B1.11B1.12B1.04B969.98M
Cash, Cash Equivalents and Short-Term Investments378.41M341.70M307.49M318.58M291.65M344.59M
Total Debt108.82M161.55M172.57M172.22M148.34M78.03M
Total Liabilities361.21M343.53M362.14M351.54M300.30M276.92M
Stockholders Equity746.94M742.63M725.94M740.55M698.65M639.50M
Cash Flow
Free Cash Flow107.78M133.76M91.54M80.71M26.40M149.17M
Operating Cash Flow130.26M145.40M148.78M190.04M110.91M172.67M
Investing Cash Flow16.06M4.13M-68.49M-134.09M-77.12M-39.26M
Financing Cash Flow-89.08M-100.00M-117.13M-53.67M-90.98M-69.21M

UMP Healthcare Holdings Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.48
Price Trends
50DMA
0.47
Positive
100DMA
0.46
Positive
200DMA
0.46
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
48.32
Neutral
STOCH
50.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0722, the sentiment is Positive. The current price of 0.48 is above the 20-day moving average (MA) of 0.48, above the 50-day MA of 0.47, and above the 200-day MA of 0.46, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 48.32 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0722.

UMP Healthcare Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
HK$376.45M11.494.28%7.10%-2.78%-24.77%
56
Neutral
HK$471.24M2.9527.04%2.00%
54
Neutral
HK$1.45B100.820.48%0.49%-2.63%
52
Neutral
HK$5.39B114.210.60%-9.81%-72.56%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
42
Neutral
HK$689.62M-2.42-15.15%18.62%44.24%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0722
UMP Healthcare Holdings Limited
0.47
0.02
3.98%
HK:2279
Yonghe Medical Group Co., Ltd.
2.07
0.88
73.51%
HK:3869
Hospital Corporation of China Ltd
3.41
-0.89
-20.70%
HK:3886
Town Health International Medical Group Ltd.
0.21
-0.02
-9.70%
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
8.78
-6.22
-41.47%
HK:2453
Concord Healthcare Group Co., Ltd. Class H
0.88
-5.05
-85.16%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 14, 2026